These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 21842614)

  • 1. Ethical issues in naturalistic versus controlled trials.
    Helmchen H
    Dialogues Clin Neurosci; 2011; 13(2):173-82. PubMed ID: 21842614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethical considerations of researchers conducting pediatric clinical drug trials: a qualitative survey in two Belgian university children's hospitals.
    Van Hoof W; Meesters K; Dossche L; Christiaens D; De Bruyne P; Vande Walle J
    Eur J Pediatr; 2018 Jul; 177(7):1003-1008. PubMed ID: 29679141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethical issues posed by cluster randomized trials in health research.
    Weijer C; Grimshaw JM; Taljaard M; Binik A; Boruch R; Brehaut JC; Donner A; Eccles MP; Gallo A; McRae AD; Saginur R; Zwarenstein M
    Trials; 2011 Apr; 12():100. PubMed ID: 21507237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is a placebo-controlled surgical trial an oxymoron?
    Boyle K; Batzer FR
    J Minim Invasive Gynecol; 2007; 14(3):278-83. PubMed ID: 17478356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethical challenges in developing drugs for psychiatric disorders.
    Carrier F; Banayan D; Boley R; Karnik N
    Prog Neurobiol; 2017 May; 152():58-69. PubMed ID: 28268181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethical issues in evidence-based surgery.
    Burger I; Sugarman J; Goodman SN
    Surg Clin North Am; 2006 Feb; 86(1):151-68, x. PubMed ID: 16442426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ethics in psychiatric research].
    Helmchen H
    Psychiatr Prax; 2014 Jul; 41 Suppl 1():S31-7. PubMed ID: 24983573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethics of clinical research with mentally ill persons.
    Helmchen H
    Eur Arch Psychiatry Clin Neurosci; 2012 Aug; 262(5):441-52. PubMed ID: 22212724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inclusion of patients with severe mental illness in clinical trials: issues and recommendations surrounding informed consent.
    Welie SP; Berghmans RL
    CNS Drugs; 2006; 20(1):67-83. PubMed ID: 16396525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stepped-wedge trials should be classified as research for the purpose of ethical review.
    Hemming K; Taljaard M; Marshall T; Goldstein CE; Weijer C
    Clin Trials; 2019 Dec; 16(6):580-588. PubMed ID: 31818147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethics of placebo-controlled clinical trials in multiple sclerosis: a reassessment.
    Polman CH; Reingold SC; Barkhof F; Calabresi PA; Clanet M; Cohen JA; Cutter GR; Freedman MS; Kappos L; Lublin FD; McFarland HF; Metz LM; Miller AE; Montalban X; O'Connor PW; Panitch H; Richert JR; Petkau J; Schwid SR; Sormani MP; Thompson AJ; Weinshenker BG; Wolinsky JS
    Neurology; 2008 Mar; 70(13 Pt 2):1134-40. PubMed ID: 18362273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ethical controversies on the use of placebo as control treatment in clinical trials in neurology].
    Lahuerta J; Gutiérrez Rivas E; Frías J; Gracia D; Dal-Ré R
    Neurologia; 2007 Mar; 22(2):106-13. PubMed ID: 17323236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical research with healthy volunteers: an ethical framework.
    Miller FG
    J Investig Med; 2003 Feb; 51 Suppl 1():S2-5. PubMed ID: 12664947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ethical challenges raised in the design and conduct of pragmatic trials: an interview study with key stakeholders.
    Nicholls SG; Carroll K; Zwarenstein M; Brehaut JC; Weijer C; Hey SP; Goldstein CE; Graham ID; Grimshaw JM; McKenzie JE; Fergusson DA; Taljaard M;
    Trials; 2019 Dec; 20(1):765. PubMed ID: 31870433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential benefit of the placebo effect in sham-controlled trials: implications for risk-benefit assessments and informed consent.
    Brim RL; Miller FG
    J Med Ethics; 2013 Nov; 39(11):703-7. PubMed ID: 23239742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethical issues of participant recruitment in surgical clinical trials.
    Angelos P
    Ann Surg Oncol; 2013 Oct; 20(10):3184-7. PubMed ID: 23975308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Informed consent and clinical trials: where is the placebo effect?
    Blease CR; Bishop FL; Kaptchuk TJ
    BMJ; 2017 Feb; 356():j463. PubMed ID: 28159769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological research on addictions: a framework for ethical and policy considerations.
    Geppert C; Bogenschutz MP
    J Psychoactive Drugs; 2009 Mar; 41(1):49-60. PubMed ID: 19455909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethical considerations for the conduct of antidementia trials in Canada.
    Fisk JD
    Can J Neurol Sci; 2007 Mar; 34 Suppl 1():S32-6. PubMed ID: 17469679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The case for evidence-based rulemaking in human subjects research.
    Sachs B
    Am J Bioeth; 2010 Jun; 10(6):3-13. PubMed ID: 20526958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.